Aurora M. Fontainhas

Array ( [id] => 11678337 [patent_doc_number] => 09676851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-13 [patent_title] => 'Human PAC1 antibodies' [patent_app_type] => utility [patent_app_number] => 14/775995 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 44419 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9719772 [patent_doc_number] => 20140255471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'METHOD OF TREATING BRAIN TUMORS' [patent_app_type] => utility [patent_app_number] => 14/202304 [patent_app_country] => US [patent_app_date] => 2014-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11186 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14202304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12044773 [patent_doc_number] => 09822367 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-21 [patent_title] => 'Inhibition of SEMA3A in the prevention and treatment of ocular hyperpermeability' [patent_app_type] => utility [patent_app_number] => 14/769255 [patent_app_country] => US [patent_app_date] => 2014-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 8 [patent_no_of_words] => 15746 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14769255 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11219902 [patent_doc_number] => 09448232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-20 [patent_title] => 'Methods and materials for detecting C9ORF72 hexanucleotide repeat expansion positive frontotemporal lobar degeneration or C9ORF72 hexanucleotide repeat expansion positive amyotrophic lateral sclerosis' [patent_app_type] => utility [patent_app_number] => 14/162570 [patent_app_country] => US [patent_app_date] => 2014-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8236 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14162570 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9596728 [patent_doc_number] => 20140193409 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-10 [patent_title] => 'FUSION PROTEINS FOR DELIVERY OF GDNF TO THE CNS' [patent_app_type] => utility [patent_app_number] => 14/144460 [patent_app_country] => US [patent_app_date] => 2013-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 42155 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14144460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9421729 [patent_doc_number] => 20140106380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'METHODS FOR IDENTIFYING INHIBITORS OF ABETA42 OLIGOMERS' [patent_app_type] => utility [patent_app_number] => 14/106468 [patent_app_country] => US [patent_app_date] => 2013-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11575 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14106468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9476641 [patent_doc_number] => 20140134103 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'TREATMENT AND PROPHYLAXIS OF AMYLOIDOSIS' [patent_app_type] => utility [patent_app_number] => 14/099692 [patent_app_country] => US [patent_app_date] => 2013-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 53533 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14099692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9560679 [patent_doc_number] => 20140178392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-26 [patent_title] => 'Nogo Receptor-Mediated Blockade of Axonal Growth' [patent_app_type] => utility [patent_app_number] => 14/088158 [patent_app_country] => US [patent_app_date] => 2013-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 31101 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14088158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9369857 [patent_doc_number] => 20140079730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-20 [patent_title] => 'COMPOSITION COMPRISING VLP AND AMYLOID BETA PEPTIDE' [patent_app_type] => utility [patent_app_number] => 14/085048 [patent_app_country] => US [patent_app_date] => 2013-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3444 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14085048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9363109 [patent_doc_number] => 20140072982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'SPECIFIC SALIVARY BIOMARKERS FOR RISK DETECTION, EARLY DIAGNOSIS, PROGNOSIS AND MONITORING OF ALZHEIMER\'S AND PARKINSON\'S DISEASES' [patent_app_type] => utility [patent_app_number] => 14/081544 [patent_app_country] => US [patent_app_date] => 2013-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16022 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14081544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10399463 [patent_doc_number] => 20150284472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-08 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING PROTEINOPATHIES' [patent_app_type] => utility [patent_app_number] => 14/440818 [patent_app_country] => US [patent_app_date] => 2013-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 26864 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10391711 [patent_doc_number] => 20150276718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-01 [patent_title] => 'THERAPEUTIC OR PROPHYLACTIC AGENT FOR RETINOPATHY OF PREMATURITY, TESTING METHOD FOR RETINOPATHY OF PREMATURITY, AND SCREENING METHOD FOR THERAPEUTIC OR PROPHYLACTIC SUBSTANCE FOR RETINOPATHY OF PREMATURITY' [patent_app_type] => utility [patent_app_number] => 14/437925 [patent_app_country] => US [patent_app_date] => 2013-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14060 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14759375 [patent_doc_number] => 10391066 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-08-27 [patent_title] => Compositions and methods for the treatment of Parkinson's disease [patent_app_type] => utility [patent_app_number] => 14/435346 [patent_app_country] => US [patent_app_date] => 2013-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 31 [patent_no_of_words] => 7812 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10380669 [patent_doc_number] => 20150265675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'Treatment of Brain Injury or Trauma with TSG-6 Protein' [patent_app_type] => utility [patent_app_number] => 14/435800 [patent_app_country] => US [patent_app_date] => 2013-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 13162 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9519324 [patent_doc_number] => 20140155816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-05 [patent_title] => 'METHOD FOR TREATING BRAIN INJURY OR STROKE' [patent_app_type] => utility [patent_app_number] => 14/049031 [patent_app_country] => US [patent_app_date] => 2013-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 8561 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14049031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9699407 [patent_doc_number] => 20140249091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'Delta-Opioid Receptor Selective Analgesics' [patent_app_type] => utility [patent_app_number] => 14/048330 [patent_app_country] => US [patent_app_date] => 2013-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14286 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14048330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11521670 [patent_doc_number] => 09605056 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Antibodies recognizing alpha-synuclein' [patent_app_type] => utility [patent_app_number] => 14/049169 [patent_app_country] => US [patent_app_date] => 2013-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18113 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14049169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9568594 [patent_doc_number] => 20140186307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-03 [patent_title] => 'Use of Stem Cells to Prevent Neuronal Dieback' [patent_app_type] => utility [patent_app_number] => 14/045582 [patent_app_country] => US [patent_app_date] => 2013-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 23163 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14045582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9338356 [patent_doc_number] => 20140065138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/039113 [patent_app_country] => US [patent_app_date] => 2013-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8070 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14039113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9408034 [patent_doc_number] => 20140099286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'CELL THERAPY FOR CHRONIC STROKE' [patent_app_type] => utility [patent_app_number] => 14/037990 [patent_app_country] => US [patent_app_date] => 2013-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6857 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14037990 [rel_patent_id] =>[rel_patent_doc_number] =>)